UTAH MEDICAL PRODUCTS, INC. AOCI Including Portion Attributable to Noncontrolling Interest, before Tax
UTAH MEDICAL PRODUCTS, INC. (UTMD) had AOCI Including Portion Attributable to Noncontrolling Interest, before Tax of -$9.95 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:AccumulatedOtherComprehensiveIncomeLossBeforeTax1 · last filed 2026-08-12
- 2026-06-30: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax -$9.95M.
- 2026-03-31: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax -$9.92M.
- 2025-12-31: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax -$9.42M.
- 2025-09-30: AOCI Including Portion Attributable to Noncontrolling Interest, before Tax -$9.74M.
| Period end | AOCI Including Portion Attributable to Noncontrolling Interest, before Tax |
|---|---|
| 2026-06-30 | -$9.95M 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$9.92M 10-Q · filed 2026-05-12 |
| 2025-12-31 | -$9.42M 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$9.74M 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$9.36M 10-Q · filed 2025-08-12 |
| 2025-03-31 | -$11.19M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$11.91M 10-K · filed 2026-03-27 |
| 2024-09-30 | -$9.89M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$11.32M 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$11.29M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$10.66M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$12.00M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$10.99M 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$11.49M 10-Q · filed 2023-05-05 |
| 2022-12-31 | -$12.04M 10-K · filed 2024-03-26 |
| 2022-09-30 | -$14.43M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$11.86M 10-Q · filed 2022-08-12 |
| 2022-03-31 | -$9.56M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$9.05M 10-K/A · filed 2023-03-28 |
| 2021-09-30 | -$9.07M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$8.29M 10-Q · filed 2021-08-06 |
| 2021-03-31 | -$8.34M 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$8.28M 10-K · filed 2022-03-25 |
| 2020-09-30 | -$10.20M 10-Q/A · filed 2020-11-09 |
| 2020-06-30 | -$11.71M 10-Q · filed 2020-08-07 |
| 2020-03-31 | -$12.23M 10-Q · filed 2020-05-08 |
| 2019-12-31 | -$9.78M 10-K · filed 2021-03-26 |
| 2019-09-30 | -$12.49M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$10.81M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$10.34M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$11.29M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$10.26M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$9.88M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$7.04M 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$8.34M 10-K · filed 2019-03-14 |
| 2017-09-30 | -$8.69M 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$9.91M 10-Q · filed 2017-08-03 |
| 2017-03-31 | -$11.59M 10-Q · filed 2017-05-05 |
| 2016-12-31 | -$12.24M 10-K · filed 2018-03-06 |
| 2016-09-30 | -$9.82M 10-Q · filed 2016-11-04 |
| 2016-06-30 | -$9.39M 10-Q · filed 2016-08-08 |
| 2016-03-31 | -$6.38M 10-Q · filed 2016-05-06 |
| 2015-12-31 | -$5.96M 10-K · filed 2017-03-08 |
| 2015-09-30 | -$4.95M 10-Q · filed 2015-11-06 |
| 2015-06-30 | -$3.41M 10-Q · filed 2015-08-07 |
| 2015-03-31 | -$5.77M 10-Q · filed 2015-05-06 |
| 2014-12-31 | -$3.23M 10-K · filed 2016-03-10 |
| 2014-09-30 | -$1.44M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $1.12M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $264.00K 10-Q · filed 2014-05-07 |
| 2013-12-31 | $16.00K 10-K · filed 2015-03-12 |
| 2013-09-30 | -$769.00K 10-Q · filed 2013-11-06 |
| 2013-06-30 | -$3.34M 10-Q · filed 2013-08-08 |
| 2012-12-31 | -$851.00K 10-K · filed 2014-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |